Dr Marie Chivers

Director

Marie is a Director at PRMA Consulting, where she has been involved in comprehensive literature reviews, manuscript authoring, GVD development, development of objection handlers, value propositions, value message testing, and strategic landscape assessment using the PRMA Healthcheck® digital application.

Marie has more than 10 years’ experience in the pharmaceutical industry working across multiple therapy areas and indications including dermatology (eczema, psoriasis), infectious diseases (HIV, malaria), rheumatoid arthritis, and oncology.

Past projects include the development of market-specific reimbursement maps for digital therapeutics and development of a global payer value proposition for a rare disease franchise.

Marie is a GPhC registered pharmacist and holds a PhD in Biopharmaceutical science (vaccine delivery systems) from University College Cork, Ireland.

Outside of work, Marie enjoys running, reading, playing music, and being a mum of two.

The insights you need to get the inside edge

Driving BioPharma Access in Europe: Insights for Markets Outside of EU5  

Welcoming Lewis Ruff, Senior Director, Global HEOR, within our policy, access, value, and evidence capability

Adapting to Change: Strategies for Pharma Service Providers, CROs, and R&D Partnerships in the Era of the Inflation Reduction Act

Forecasting global value assessments for a rare-disease drug

Welcoming Tyler Piazza, Partnerships Director, HEOR and hēRo3, within our policy, access, value, and evidence capability

Welcoming Caroline Solon, Senior Director Global Market Access, within our policy, access, value, and evidence capability

Cross-functional integrated evidence generation planning for a therapy treating ANCA‑associated vasculitis (AAV)

Digital therapeutics: policy, access, value, and evidence

The hēRo3 Revolution: Accelerating and Empowering HEOR Analytics with Cutting-Edge Digital Solutions

Value, Evidence, and Access: insights for markets outside of the EU5